tirzepatide vs semaglutide brand name vs. for Weight Loss The infographic compares 10 commonly

Meta-analyses have further confirmed that dual GLP-1/GIP receptor agonists are more effective than single GLP-1RAs in reversing liver fibrosis and reducing hepatic fat accumulation, suggesting a dose-dependent and receptor-combinatorial effect on liver outcomes (48)

Less Food = Less Fluid Many people eat less when taking GLP-1s, which also means theyre consuming fewer hydrating foods, such as fruits, vegetables, and soups

Furthermore, lower concentrations of DPP-IV are inversely associated with increased disease activity, although is not clear whether this is the cause or consequence of disease

Medical History Failed weight loss attempts through diet and exercise

call NHS 111 or attend A&E Any new neck lump, difficulty swallowing, or persistent hoarseness seek prompt assessment to exclude thyroid pathology Changes in vision in people with diabetes seek prompt ophthalmic review For non-emergency concerns, NHS 111 can provide guidance on whether and how quickly to seek further care

Risks, White Spaces, and Recommendations Key Risks Efficacy ceiling anxiety : As multi-agonists push weight loss toward 2025%, the marginal benefit of each new mechanism narrows